ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 373 filers reported holding ENCOMPASS HEALTH CORP in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86,559,703 | +4.4% | 1,288,858 | +5.3% | 0.07% | +9.2% |
Q2 2023 | $82,905,207 | +30.4% | 1,224,416 | +4.2% | 0.06% | +38.3% |
Q1 2023 | $63,590,330 | -20.6% | 1,175,422 | -12.2% | 0.05% | -25.4% |
Q4 2022 | $80,073,090 | +34.9% | 1,338,791 | +2.0% | 0.06% | +28.6% |
Q3 2022 | $59,341,000 | +4.8% | 1,311,981 | +3.2% | 0.05% | +11.4% |
Q2 2022 | $56,635,000 | -33.4% | 1,270,833 | +6.2% | 0.04% | -22.8% |
Q1 2022 | $85,098,000 | +29.0% | 1,196,703 | +18.4% | 0.06% | +42.5% |
Q4 2021 | $65,954,000 | +20.5% | 1,010,629 | +38.6% | 0.04% | +17.6% |
Q3 2021 | $54,711,000 | -3.4% | 729,088 | +0.5% | 0.03% | +3.0% |
Q2 2021 | $56,622,000 | -6.8% | 725,647 | -2.2% | 0.03% | -13.2% |
Q1 2021 | $60,741,000 | -4.0% | 741,649 | -3.1% | 0.04% | -7.3% |
Q4 2020 | $63,263,000 | +58.3% | 765,066 | +24.4% | 0.04% | +51.9% |
Q3 2020 | $39,954,000 | +9458.4% | 614,870 | +8493.6% | 0.03% | – |
Q1 2019 | $418,000 | -34.1% | 7,155 | -30.8% | 0.00% | -100.0% |
Q4 2018 | $634,000 | – | 10,339 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |